Synonyms: OMP-18R5
Vantictumab (Anti-FZD) is a monoclonal antibody targeting the Wnt signaling pathway with potential antineoplastic activity. Vantictumab binds to certain receptors in the Wnt signaling pathway thereby preventing the activation of the Wnt signaling pathway. This results in an inhibition of cancer stem cell (CSC) activity and a subsequent inhibition of cancer cell proliferation. MW: 145.5 KD.
| Name | Citation | WNT | β-catenin | Wnt/β-catenin | Others |
|---|---|---|---|---|---|
| IWR-1-endo | 167 | ||||
| IWP-2 | 135 | <sup>M82F</sup>CK1δ | |||
| JW74 | 1 | ||||
| IWP-4 | 1 | ||||
| CCT251545 | 3 | CDK19,CDK8 | |||
| KY1220 | 0 | Ras | |||
| iCRT14 | 5 | ||||
| iCRT3 | 10 | ||||
| LF3 | 20 | ||||
| PNU-74654 | 24 | ||||
| KYA1797K | 16 | ||||
| KY02111 | 9 | ||||
| Zamaporvint (RXC004) | 0 | ||||
| M2912 | 0 | TNKS2,TNKS1,axin2 | |||
| M435-1279 | 1 | ||||
| KY-05009 | 1 | TNIK | |||
| Prodigiosin | 0 | ||||
| Ginsenoside Rh4 | 0 | ||||
| Heparan Sulfate | 10 | ||||
| RCM-1 | 5 | FOXM1,STAT6,IL-13 | |||
| Resibufogenin | 3 | Caspase-3,ROS,p-GSK3β | |||
| MSAB | 9 | ||||
| PRI-724 (Foscenvivint) | 32 | CBP | |||
| Tegatrabetan (BC-2059) | 4 | ||||
| JW55 | 3 | ||||
| Adavivint (SM04690) | 8 | ||||
| Triptonide | 2 | ||||
| Isoquercitrin | 6 | ||||
| IQ-1 | 4 | ||||
| Salinomycin (Procoxacin) | 22 | ||||
| FH535 | 20 | PPARδ,PPARγ |
| Description |
Vantictumab (Anti-FZD) is a monoclonal antibody targeting the Wnt signaling pathway with potential antineoplastic activity. Vantictumab binds to certain receptors in the Wnt signaling pathway thereby preventing the activation of the Wnt signaling pathway. This results in an inhibition of cancer stem cell (CSC) activity and a subsequent inhibition of cancer cell proliferation. MW: 145.5 KD.
|
|---|
| CAS No. | 1345009-45-1 |
|---|---|
| Molecular Weight | 145.5 kDa |
| Isotype | Human IgG2SA |
| Source | CHO |
| Purification | AKTA |
| Sterility | 0.2 μM filtered |
| Formulation | 100 mM Pro-Ac, 20mM Arg, pH5.0 |
| Storage (From the date of receipt) |
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.